These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 27532807)

  • 21. Passive immunotherapy for Middle East Respiratory Syndrome coronavirus infection with equine immunoglobulin or immunoglobulin fragments in a mouse model.
    Zhao Y; Wang C; Qiu B; Li C; Wang H; Jin H; Gai W; Zheng X; Wang T; Sun W; Yan F; Gao Y; Wang Q; Yan J; Chen L; Perlman S; Zhong N; Zhao J; Yang S; Xia X
    Antiviral Res; 2017 Jan; 137():125-130. PubMed ID: 27890674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sero-prevalence of Middle East respiratory syndrome coronavirus (MERS-CoV) specific antibodies in dromedary camels in Tabuk, Saudi Arabia.
    Harrath R; Abu Duhier FM
    J Med Virol; 2018 Aug; 90(8):1285-1289. PubMed ID: 29663439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kinetics of antibody response in critically ill patients with Middle East respiratory syndrome and association with mortality and viral clearance.
    Arabi YM; Hajeer AH; Balkhy H; Al Johani S; Sadat M; Al-Dawood A; Abu Taleb A; Jose J; Al Qasim E; Al Ajlan A
    Sci Rep; 2021 Nov; 11(1):22548. PubMed ID: 34799590
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of MERS coronavirus neutralizing antibodies in humans, eastern province, Saudi Arabia.
    Gierer S; Hofmann-Winkler H; Albuali WH; Bertram S; Al-Rubaish AM; Yousef AA; Al-Nafaie AN; Al-Ali AK; Obeid OE; Alkharsah KR; Pöhlmann S
    Emerg Infect Dis; 2013 Dec; 19(12):2034-6. PubMed ID: 24274664
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial.
    Folegatti PM; Bittaye M; Flaxman A; Lopez FR; Bellamy D; Kupke A; Mair C; Makinson R; Sheridan J; Rohde C; Halwe S; Jeong Y; Park YS; Kim JO; Song M; Boyd A; Tran N; Silman D; Poulton I; Datoo M; Marshall J; Themistocleous Y; Lawrie A; Roberts R; Berrie E; Becker S; Lambe T; Hill A; Ewer K; Gilbert S
    Lancet Infect Dis; 2020 Jul; 20(7):816-826. PubMed ID: 32325038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of Serologic Assays for Middle East Respiratory Syndrome Coronavirus.
    Harvey R; Mattiuzzo G; Hassall M; Sieberg A; Müller MA; Drosten C; Rigsby P; Oxenford CJ;
    Emerg Infect Dis; 2019 Oct; 25(10):1878-1883. PubMed ID: 31423969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of a diagnostic system for detection of specific antibodies and antigens against Middle East respiratory syndrome coronavirus.
    Lee K; Ko HL; Lee EY; Park HJ; Kim YS; Kim YS; Cho NH; Park MS; Lee SM; Kim J; Kim H; Seong BL; Nam JH
    Microbiol Immunol; 2018 Sep; 62(9):574-584. PubMed ID: 30117617
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV.
    Zhao G; He L; Sun S; Qiu H; Tai W; Chen J; Li J; Chen Y; Guo Y; Wang Y; Shang J; Ji K; Fan R; Du E; Jiang S; Li F; Du L; Zhou Y
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29950421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single-dose treatment with a humanized neutralizing antibody affords full protection of a human transgenic mouse model from lethal Middle East respiratory syndrome (MERS)-coronavirus infection.
    Qiu H; Sun S; Xiao H; Feng J; Guo Y; Tai W; Wang Y; Du L; Zhao G; Zhou Y
    Antiviral Res; 2016 Aug; 132():141-8. PubMed ID: 27312105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Qualitative and Quantitative Determination of MERS-CoV S1-Specific Antibodies Using ELISA.
    Al-Amri SS; Hashem AM
    Methods Mol Biol; 2020; 2099():127-133. PubMed ID: 31883093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of Middle East Respiratory Syndrome Coronavirus-Specific RNA and Anti-MERS-Receptor-Binding Domain Antibodies in Camel Milk from Different Regions of Saudi Arabia.
    Alshehri A; Mir NA; Miled N
    Viral Immunol; 2022 Dec; 35(10):673-680. PubMed ID: 36534466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigation of anti-middle East respiratory syndrome antibodies in blood donors and slaughterhouse workers in Jeddah and Makkah, Saudi Arabia, fall 2012.
    Aburizaiza AS; Mattes FM; Azhar EI; Hassan AM; Memish ZA; Muth D; Meyer B; Lattwein E; Müller MA; Drosten C
    J Infect Dis; 2014 Jan; 209(2):243-6. PubMed ID: 24218504
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human neutralizing antibodies against MERS coronavirus: implications for future immunotherapy.
    Tang XC; Marasco WA
    Immunotherapy; 2015; 7(6):591-4. PubMed ID: 26098703
    [No Abstract]   [Full Text] [Related]  

  • 34. Phylogenetic Analysis of MERS-CoV in a Camel Abattoir, Saudi Arabia, 2016-2018.
    Hemida MG; Chu DKW; Chor YY; Cheng SMS; Poon LLM; Alnaeem A; Peiris M
    Emerg Infect Dis; 2020 Dec; 26(12):3089-3091. PubMed ID: 33219804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of an antibody-dependent cellular cytotoxicity reporter assay for measuring anti-Middle East Respiratory Syndrome antibody bioactivity.
    Cao J; Wang L; Yu C; Wang K; Wang W; Yan J; Li Y; Yang Y; Wang X; Wang J
    Sci Rep; 2020 Oct; 10(1):16615. PubMed ID: 33024203
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment outcomes for patients with Middle Eastern Respiratory Syndrome Coronavirus (MERS CoV) infection at a coronavirus referral center in the Kingdom of Saudi Arabia.
    Al Ghamdi M; Alghamdi KM; Ghandoora Y; Alzahrani A; Salah F; Alsulami A; Bawayan MF; Vaidya D; Perl TM; Sood G
    BMC Infect Dis; 2016 Apr; 16():174. PubMed ID: 27097824
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recombinant Receptor-Binding Domains of Multiple Middle East Respiratory Syndrome Coronaviruses (MERS-CoVs) Induce Cross-Neutralizing Antibodies against Divergent Human and Camel MERS-CoVs and Antibody Escape Mutants.
    Tai W; Wang Y; Fett CA; Zhao G; Li F; Perlman S; Jiang S; Zhou Y; Du L
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795425
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Competitive ELISA for the Detection of Serum Antibodies Specific for Middle East Respiratory Syndrome Coronavirus (MERS-CoV).
    Fukushi S
    Methods Mol Biol; 2020; 2203():55-65. PubMed ID: 32833203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of serological assays in human Middle East respiratory syndrome (MERS)-coronavirus infection.
    Park SW; Perera RA; Choe PG; Lau EH; Choi SJ; Chun JY; Oh HS; Song KH; Bang JH; Kim ES; Kim HB; Park WB; Kim NJ; Poon LL; Peiris M; Oh MD
    Euro Surveill; 2015; 20(41):. PubMed ID: 26538277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A dual-targeting approach using a human bispecific antibody against the receptor-binding domain of the Middle East Respiratory Syndrome Coronavirus.
    Lee JH; Kim JW; Lee HE; Song JY; Cho AH; Hwang JH; Heo K; Lee S
    Virus Res; 2024 Jul; 345():199383. PubMed ID: 38697296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.